Drugs Made In America Acquisition II Corp. - Right (DMIIR) closed at $0.07 on October 27, 2026, up 16.7% from the previous close, on volume of 18,214 shares (30-day average 28,004).
Data as of October 27, 2026.
No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition II Corp. - Right trades on the stock market under the symbol DMIIR.
As of October 27, 2026, DMIIR stock price climbed to $0.07 with 18,214 million shares trading.
DMIIR has a beta of -0.45, meaning it tends to be less sensitive to market movements. DMIIR has a correlation of 0.00 to the broad based SPY ETF.
DMIIR has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMIIR support price is $.05 and resistance is $.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMIIR shares will trade within this expected range on the day.
